Co-Diagnostics, Inc. Deferred Revenue Recognized
Co-Diagnostics, Inc. (CODX) reported Deferred Revenue Recognized of $14.80 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-08-13
- Co-Diagnostics, Inc. contract with customer, liability, revenue recognized for the quarter ending 2026-03-31 was $14.80K.
- Co-Diagnostics, Inc. contract with customer, liability, revenue recognized for the quarter ending 2022-03-31 was $150.00K.
- Co-Diagnostics, Inc. contract with customer, liability, revenue recognized for the quarter ending 2021-03-31 was -$200.07K.
- Co-Diagnostics, Inc. contract with customer, liability, revenue recognized for fiscal 2025 was $40.86K, a 86.47% decline from fiscal 2024.
- Co-Diagnostics, Inc. contract with customer, liability, revenue recognized for fiscal 2024 was $301.97K.
- Co-Diagnostics, Inc. contract with customer, liability, revenue recognized for fiscal 2022 was $150.00K, a 41.43% decline from fiscal 2021.
- Co-Diagnostics, Inc. contract with customer, liability, revenue recognized for fiscal 2021 was $256.11K, a 19258.28% increase from fiscal 2020.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month | Contract with Customer, Liability, Revenue Recognized 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $14.80K 10-Q · filed 2026-08-13 | ||||
| 2026-03-31 | $14.80K 10-Q · filed 2026-05-14 | ||||
| 2025-12-31 | $40.86K 10-K · filed 2026-03-31 | ||||
| 2024-12-31 | $301.97K 10-K · filed 2026-03-31 | ||||
| 2022-12-31 | $150.00K 10-K · filed 2023-03-16 | ||||
| 2022-09-30 | $150.00K 10-Q · filed 2022-11-10 | ||||
| 2022-06-30 | $150.00K 10-Q · filed 2022-08-11 | ||||
| 2022-03-31 | $150.00K 10-Q · filed 2022-05-12 | ||||
| 2021-12-31 | $256.11K 10-K · filed 2023-03-16 | ||||
| 2021-09-30 | $194.96K 10-Q · filed 2021-11-12 | ||||
| 2021-06-30 | $194.06K 10-Q · filed 2021-08-12 | ||||
| 2021-03-31 | -$200.07K 10-Q · filed 2021-05-13 | ||||
| 2020-12-31 | $1.32K 10-K · filed 2022-03-24 | -$1.32K 10-K · filed 2021-03-25 | |||
| 2020-09-30 | -$1.32K 10-Q · filed 2020-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |